Results 151 to 160 of about 100,852 (314)
Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin [PDF]
A. H. Henderson, J. E. G. Pearson
openalex +1 more source
Mapping Bullous Emphysema With Lung Ultrasound: A Prospective Multicentre Study
This study confirms the existence of the ‘bulla‐point’, a sonographic sign echoing the lung‐point associated with pneumothorax. Other signs of pneumothorax such as absent lung sliding or barcode sign are also prevalent in bullous emphysema, especially in patients with high pulmonary distension or in apical regions.
Kinan El Husseini+8 more
wiley +1 more source
Abstract The food enzyme aspergillopepsin I (EC 3.4.23.18) is produced with the non‐genetically modified Aspergillus sp. strain AE‐PRHF by AMANO ENZYME INC. The food enzyme was free from viable cells of the production organism. It is intended to be used in 15 food manufacturing processes. Since residual amounts of food enzyme–total organic solids (TOS)
EFSA Panel on Food Enzymes (FEZ)+18 more
wiley +1 more source
Significance and interpretation of laboratory tests in pulmonary aspergillosis [PDF]
M. P. English, A. H. Henderson
openalex +1 more source
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. [PDF]
There are limited treatment options for immunosuppressed patients with lethal invasive fungal infections due to Fusarium and Scedosporium Manogepix (MGX; APX001A) is a novel antifungal that targets the conserved Gwt1 enzyme required for localization of ...
Alkhazraji, Sondus+8 more
core +1 more source
Aspergillus fumigatus and aspergillosis: From basics to clinics
A. Arastehfar+20 more
semanticscholar +1 more source
Transient Pulmonary Infiltrations in Cystic Fibrosis due to Allergic Aspergillosis [PDF]
M B Mearns, Warren Young, J C Batten
openalex +1 more source
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
A. Alanio+4 more
semanticscholar +1 more source